U.S. Biotech Stock News

Sandisk (SNDK) has just posted Q2 2026 numbers with revenue of US$3.0 billion and basic EPS of US$5.46, alongside net income of US$803 million. This puts a very different quarterly picture next to the trailing 12 month loss of US$1.0 billion and basic EPS of US$7.15 in the red. Over the last six reported quarters, revenue has moved from US$1.9 billion in Q2 2025 to US$3.0 billion in Q2 2026. Over the same period, quarterly basic EPS has swung from losses of US$0.72 and US$13.33 in 2025 to...

If you are wondering whether Royal Caribbean Cruises is still offering value after its big run, you are not alone. This article focuses squarely on what you are paying for the business today. The stock last closed at US$324.65, with returns of 13.5% over 7 days, 14.6% over 30 days, 14.6% year to date, 23.3% over 1 year, and very large gains over 3 and 5 years that signal a major shift in how the market is pricing the company. These moves have been set against ongoing interest in the cruise...

Silicon Motion Technology (SIMO) just picked up Clarivate’s 2026 Top 100 Global Innovators recognition, spotlighting its NAND flash controller and AI storage work, as investors weigh that accolade alongside earnings expectations and brokerage sentiment. See our latest analysis for Silicon Motion Technology. The recent Clarivate award and upbeat brokerage sentiment have arrived alongside strong momentum, with a 26.85% 1 month share price return and a 124.60% 1 year total shareholder return...

If you are wondering whether Main Street Capital's share price still makes sense at today's level, or if the value story has already played out, this article breaks down what the current price might be implying about the business. The stock last closed at US$63.80, with returns of 3.3% over the past month, 3.3% year to date and 10.6% over the past year, set against a very large 3 year return and a 178.1% return over 5 years. Recent news coverage has highlighted Main Street Capital's role as...

If you are asking whether TD SYNNEX is priced attractively today, the starting point is to look calmly at what the current market price might already be assuming. The stock last closed at US$158.67, with returns of 3.6% over 7 days, 3.4% over 30 days, 3.4% year to date, 12.8% over 1 year, 57.6% over 3 years and 92.9% over 5 years. This gives you a clear snapshot of how the market has treated the shares over different time frames. Recent coverage has focused on TD SYNNEX in the context of...

In late January 2026, Old Second Bancorp, Inc. announced a US$43.9 million share repurchase program, following Federal Reserve Bank of Chicago non-objection, alongside fourth-quarter 2025 results showing higher net interest income and earnings versus the prior year. Together with a recently declared US$0.07 per-share cash dividend, the buyback underscores management’s focus on returning capital while highlighting both strong net interest margin and elevated Powersports credit costs. We’ll...

In late January 2026, analysts upgraded their views on Relay Therapeutics after new clinical data showed consistent efficacy for its investigational breast cancer drug zovegalisib and highlighted potential competitive advantages versus other PI3K-pathway therapies. At the same time, several Relay Therapeutics executives sold shares primarily to cover tax obligations tied to vesting restricted stock units, underscoring how insider activity can coincide with improving sentiment around the...

Dividend increase and why it matters for Magnolia Oil & Gas (MGY) Magnolia Oil & Gas (MGY) has caught investor attention after its board approved a 10% increase to the quarterly dividend, extending a five year pattern of higher payouts since 2021. The new dividend is set at US$0.165 per Class A share and per Class B unit, payable on March 2, 2026, to shareholders of record as of February 10, 2026, which equates to an annualized US$0.66 per share. Management linked this decision to recent...

In late January 2026, Satellogic Inc. announced an 11-month extension of its agreement with the Government of Albania to provide country-wide, high-frequency satellite monitoring via its NewSat constellation, including ongoing 50 cm-resolution coverage and support for Albania-1 and Albania-2. This renewal underscores how a smaller European nation is embedding persistent satellite intelligence into day-to-day governance, moving beyond one-off, event-driven imagery requests. We’ll now examine...

In January 2026, KeyCorp reported fourth-quarter and full-year 2025 results showing higher net interest income of US$1,215 million for the quarter and US$4.64 billion for the year, alongside a swing from a prior-year loss to net income of US$510 million for the quarter and US$1.83 billion for the year. Alongside the earnings release, KeyCorp strengthened its balance sheet flexibility with a US$750 million fixed-to-floating senior notes issuance due 2037 and modest share repurchases, while...

If you are wondering whether Dynavax Technologies is priced attractively today, this article walks through what the current share price might mean for you as an investor. Over the last year the stock has returned 18.7%, while the 7 day move sits at a 0.2% decline and the year to date return is 0.7%. These shifts may have influenced how some investors view its potential and risk. Recent news around Dynavax Technologies has focused on its role in the broader pharmaceuticals and biotech space,...

Hilltop Holdings (HTH) is back in focus after its Q4 2025 report topped market expectations, alongside an 11% dividend increase and a new US$125 million share repurchase authorization from the board. See our latest analysis for Hilltop Holdings. Investors have reacted positively to the stronger earnings, dividend increase and continued buybacks, with the share price up 10.47% over the past month and a 1 year total shareholder return of 26.94%. This suggests momentum has been building rather...

What Virtus Investment Partners’ Recent Performance Tells Investors Virtus Investment Partners (VRTS) has drawn attention after recent share moves, with the stock down about 1.6% over the past day and 2.1% over the past week, while showing small gains over the month and past 3 months. For investors watching returns, the stock’s year to date gain of roughly 0.5% sits alongside a 13.5% decline over the past year and a 24.2% total return decline over three years, offering a mixed picture of...

Eastman Chemical (NYSE:EMN) is pushing ahead with a broad cost-cutting program after a challenging year for earnings. The company has raised its dividend for the 16th consecutive year, returning more cash to shareholders. Management is prioritizing high-value product lines and operational efficiency while reporting lower annual revenue and profit. Eastman Chemical, a global specialty materials company, operates at the intersection of chemicals, plastics, and advanced materials that feed...

Sprouts Farmers Market recently opened its first New York store in Centereach, Long Island, on January 30, featuring a specialty assortment of fresh, natural and organic groceries. This move extends Sprouts’ footprint into a new regional market, reinforcing its focus on serving consumers seeking lifestyle-oriented options such as organic, plant-based and gluten-free products. We’ll now examine how Sprouts’ entry into the New York market shapes its investment narrative around geographic...

Avnet (AVT) shares have been in focus after a strong quarterly earnings report that paired broad-based sales growth with improved operational efficiency, tighter inventory management, and margin expansion, along with upbeat guidance for the next quarter. See our latest analysis for Avnet. That earnings beat and upbeat guidance have arrived alongside a sharp shift in sentiment, with a 7 day share price return of 22.74% and a 30 day share price return of 26.45% at US$62.39. The 1 year total...

Labcorp Holdings (LH) recently amended its receivables purchase agreement, extending the facility to January 26, 2029 and adding a $125 million accordion feature, giving the company additional flexibility around short term funding needs. See our latest analysis for Labcorp Holdings. At a share price of $271.52, Labcorp Holdings has seen a 7.9% year to date share price return and a 9.9% 1 year total shareholder return. This suggests steady but not explosive momentum as the receivables...

Carpenter Technology (CRS) shares are in focus after the company reported record second quarter operating income, stronger aerospace and defense bookings, and raised its full year 2026 operating income guidance by 30% to 33%. See our latest analysis for Carpenter Technology. The latest results and guidance landed alongside a 1-day share price return of 2.4% to US$317.83, even though the 30-day share price return is a 6.1% decline. At the same time, the 1-year total shareholder return of 65.2%...

A class action lawsuit has been filed against Beyond Meat, alleging false or misleading statements related to asset impairments. The suit also challenges delays in the company’s financial reporting and the transparency of its disclosures. The legal action targets Beyond Meat’s executive decision making and communication with investors in recent reporting periods. For investors watching NasdaqGS:BYND, this lawsuit lands at a time when the stock has already seen sharp pressure. The share...

Huntington Ingalls Industries (HII) is back in focus after the USS John F. Kennedy aircraft carrier left its Newport News Shipbuilding division for sea trials, a key milestone on a complex, long-cycle naval contract. See our latest analysis for Huntington Ingalls Industries. Those carrier sea trials come on top of recent progress across HII, including completion of builder’s sea trials for USS Zumwalt and new long term engineering work under the ATSP5 contract, alongside leadership changes at...

In November 2025, uniQure reported that the FDA had informed the company that data from its Phase I/II AMT-130 gene therapy trial were not sufficient to support a Biologics License Application, leaving the timing of any filing uncertain. This FDA feedback places greater emphasis on the robustness of uniQure’s clinical data packages and could reshape perceptions of its gene therapy pipeline. We’ll now examine how the FDA’s stance on AMT-130’s Phase I/II data influences uniQure’s investment...

Ryan Specialty Holdings recently reported that its core business expanded through average organic revenue growth of 12.8% annually over the past two years, alongside strong long-term earnings per share growth and high free cash flow margins. This combination of internally driven revenue expansion and substantial free cash generation highlights Ryan Specialty’s ability to grow its operations while still returning capital to investors. Next, we’ll examine how Ryan Specialty’s strong organic...

Old National Bancorp completed a $450 million fixed income offering, adding a new layer of funding flexibility. Management also reported continued progress in integrating Bremer Bank into the broader Old National platform. These updates come alongside a recent share price of $24.43 for NasdaqGS:ONB, with the stock up 8.3% over the past month. For you as an investor, the combination of fresh financing and ongoing Bremer Bank integration provides more context around how Old National Bancorp...

In January 2026, Banner Corporation reported fourth-quarter and full-year 2025 results showing higher net interest income and net income, lower net charge-offs than a year earlier, continued share repurchases totaling 499,975 shares for US$31.49 million, and a regular quarterly dividend of US$0.50 per share payable on February 13, 2026. Beyond the headline earnings growth, the combination of rising net interest income, disciplined credit costs, and concurrent dividends and buybacks...